Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$238,339.80
% of Total Estimate Gain
12.51%

Cannon Global Investment Management, LLC's ACADIA Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Cannon Global Investment Management, LLC held - shares of ACADIA Pharmaceuticals Inc(ACAD), totaling N/A. This investment constitutes 0% of their stock portfolio, and Cannon Global Investment Management, LLC now holds 0% of the outstanding ACADIA Pharmaceuticals Inc(ACAD) stock.

The initial trade took place in 2024Q4. And since then Cannon Global Investment Management, LLC has made 1 purchases of ACAD, at an average price of $16.15, for a total of 117,990.00 shares. In addition, there have been 1 sales at an average price of $18.17 for 117,990.00 shares. Based on historical transaction data and ACAD's current price of $22.56, Cannon Global Investment Management, LLC's estimated gain on his ACAD holdings is $238,339.80, reflecting a 12.51% gain to date.

Cannon Global Investment Management, LLC ACAD ($22.56) Holding Chart

Cannon Global Investment Management, LLC ACAD ($22.56) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1